Cosciens Biopharma Inc.TSX: CSCI

Aeterna Zentaris Announces TSX Approval of Series B Warrant Amendment

· Issued by Cosciens Biopharma Inc.

Paul Burroughs, Director of Communications, (418) 652-8525 ext. 406, pburroughs@aezsinc.comCopyright CNW Group 2015